(Press-News.org) Petrina Kamya, PhD, Head of AI Platforms and President of Insilico Medicine Canada, will present at the BIO CEO & Investor Conference happening Feb. 26-27 at the New York Marriott Marquis in New York City. Dr. Kamya will speak as part of the panel “AI within Biopharma: Separating Value from Hype,” on Feb. 27, 1pm ET along with Michael Nally, CEO of Generate: Biomedicines and Liz Schwarzbach, PhD, CBO of BigHat Biosciences.
The session will look at how the latest artificial intelligence (AI) tools – including generative AI and large language models – are currently being used to advance the discovery and design of new drugs, and which technologies are still in development.
The BIO CEO & Investor Conference brings together over 1,000 attendees and more than 700 companies across industry and institutional investment to discuss the future investment landscape of biotechnology. Sessions focus on topics such as therapeutic advancements, market outlook, and policy priorities.
Insilico Medicine is a leading, clinical stage AI-driven drug discovery company that has raised over $400m in investments since it was founded in 2014. Dr. Kamya leads the development of the Company’s end-to-end generative AI platform, Pharma.AI from Insilico’s AI R&D Center in Montreal. Using modern machine learning techniques in the context of chemistry and biology, the platform has driven the discovery and design of 30+ new therapies, with five in clinical stages – for cancer, fibrosis, inflammatory bowel disease (IBD), and COVID-19. The Company's lead drug, for the chronic, rare lung condition idiopathic pulmonary fibrosis, is the first AI-designed drug for an AI-discovered target to reach Phase II clinical trials with patients. Nine of the top 20 pharmaceutical companies have used Insilico’s AI platform to advance their programs, and the Company has a number of major strategic licensing deals around its AI-designed therapeutic assets, including with Sanofi, Exelixis and Menarini.
About Insilico Medicine
Insilico Medicine, a global clinical stage biotechnology company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. www.insilico.com
END
Petrina Kamya, Ph.D., Head of AI Platforms at Insilico Medicine, presents at BIO CEO & Investor Conference
2024-02-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
The fate of drug discovery in academia; dumping in the publication landfill?
2024-02-05
“[...] fruitful efforts to bring more drugs from bench to bedside could only be possible if we do not leave them ‘midway’!”
BUFFALO, NY- February 5, 2024 – A new editorial paper was published in Oncotarget's Volume 15 on January 24, 2024, entitled, “The fate of drug discovery in academia; dumping in the publication landfill?”
In this new editorial, researchers Uzma Saqib, Isaac S. Demaree, Alexander G. Obukhov, Mirza S. Baig, Amiram Ariel, and Krishnan Hajela, from Devi Ahilya Vishwavidyalaya, Indore, discuss drug discovery—a tedious process that is time consuming in both divulging whether a molecule is efficacious and specific in hitting ...
Currently stable parts of East Antarctica may be closer to melting than anyone realized
2024-02-05
In a warming climate, meltwater from Antarctica is expected to contribute significantly to rising seas. For the most part, though, research has been focused on West Antarctica, in places like the Thwaites Glacier, which has seen significant melt in recent decades.
In a paper published Jan. 19 in Geophysical Research Letters, researchers at Stanford have shown that the Wilkes Subglacial Basin in East Antarctica, which holds enough ice to raise global sea levels by more than 10 feet, could be closer to runaway melting than anyone realized.
“There hasn’t been much analysis in this region – there’s huge ...
System for early diagnosis of gastrointestinal cancers
2024-02-05
Gastrointestinal cancers (GCs) are among the most common forms of cancer and account for as much as one-third of all cancer deaths worldwide. Early diagnosis is an effective way of reducing the mortality associated with GCs, and endoscopic screening has proved to be an excellent approach for detecting potentially malignant tumors.
To extend the benefits of screening programs to as many people as possible, the imaging systems used should be inexpensive to manufacture and operate, yet accurate enough ...
Study: weight loss surgery most effective for long-term blood pressure control
2024-02-05
Bariatric surgery is more effective in controlling hypertension rates, or high blood pressure, in people with obesity and uncontrolled high blood pressure compared to blood pressure medication alone, according to a study published today in the Journal of the American College of Cardiology. People who underwent bariatric surgery had lower BMI and were on fewer medications after five years while maintaining normal blood pressure levels than those who only used antihypertensive medications.
According to the CDC, the U.S. obesity and hypertension rates in adults are 41.9% and 45.4%, respectively. Obesity is a known ...
Study confirms fears that COVID pandemic reduced kindergarten readiness
2024-02-05
Numerous studies have raised alarms about how the COVID-19 pandemic disrupted learning, development and mental health among school-aged children. But few have focused on the effects felt by the 22 million children under age 6 who were not yet in school.
Now a study published Feb. 5, 2024, in JAMA Pediatrics, led by researchers at Cincinnati Children’s in collaboration with the Cincinnati Public Schools, documents the pandemic’s harmful effects on kindergarten readiness. The findings are based on data from about 8,000 kindergartners who took ...
MSU making voice-activated artificial intelligence more accessible
2024-02-05
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
EAST LANSING, Mich. – As artificial intelligence technology advances, one area lags behind: voice-activated AI. For the more than 80 million people who stutter, voice AI technologies, which are increasingly being used in job hiring practices, can still be impossible to navigate.
HeardAI, a multidisciplinary project from Michigan State University, Western Michigan University, and the nonprofit Friends: The National Association of Young People Who Stutter, has advanced to Phase 2 of the National Science Foundation’s Convergence Accelerator program to ...
Lowder & Foudray receive funding for Fairfax county peer recovery services evaluability assessment
2024-02-05
Lowder & Foudray Receive Funding For Fairfax County Peer Recovery Services Evaluability Assessment
Evan Marie Lowder, Assistant Professor, Criminology, Law and Society, and Chelsea Foudray, Postdoctoral Research Fellow, Criminology, Law and Society, received funding from County of Fairfax for: "Fairfax County Peer Recovery Services Evaluability Assessment."
Lowder and Foudray are laying the groundwork for a formal evaluation of Fairfax County Peer Recovery Services (PRS) programming.
For ...
Watching the enzymes that convert plant fiber into simple sugars
2024-02-05
This work was adapted from articles by Elizabeth Boatman and Emily C. Dooley.
Research from Lawrence Berkeley National Laboratory (Berkeley Lab), Lawrence Livermore National Laboratory (LLNL), and UC Davis sheds new light on how to access the sugars locked up in plants to produce petroleum-free fuels, chemicals, and medicines.
Using microbes to convert grasses, weeds, wood, and other plant residues into sustainable products will be key to achieving carbon neutrality and could even help eliminate drug shortages. But cellulose, the tough tissue that makes up a large proportion of herbaceous and woody plant ...
Argonne’s Lin X. Chen receives the Mildred Dresselhaus Guest Professorship Award from the University of Hamburg
2024-02-05
Lin X. Chen, a chemist at the U.S. Department of Energy’s Argonne National Laboratory, has received the Senior Prize as part of the two 2023 Mildred Dresselhaus Guest Professorship Awards from the University of Hamburg, Germany. The award recognizes outstanding international women scientists and offers an opportunity for awardees to conduct research at the Hamburg Centre for Ultrafast Imaging Cluster of Excellence. Chen has held a joint appointment as professor of chemistry at Northwestern University since 2007.
“I am very honored ...
Hart receives funding for boot camp
2024-02-05
Hart Receives Funding For Boot Camp
David M. Hart, Professor, Schar School of Policy and Government, received funding for: "2024 Climate-Tech Innovation Policy 'Boot Camp' for Early Career Researchers."
Via this effort, Hart will build interpersonal bridges across the gap that separates the policy and research communities, sensitize researchers to the practical considerations that shape energy and climate innovation policy, and create new inter-disciplinary linkages among early-career researchers.
His long-term objective is to shape the research agendas of the participating scholars, so that they contribute as fully as ...